Amyloids in bacterial inclusion bodies

Trends in Biochemical Sciences

Volumn 34, Issue 8, 2009, Pages 408-416

  de Groot, Natalia S ^a   Sabate, Raimon ^a   Ventura, Salvador ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN;

BACTERIAL CELL; BACTERIAL VIRULENCE; CELL INCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

AMYLOID; BACTERIA; INCLUSION BODIES; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, BIOLOGICAL; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY;

BACTERIA (MICROORGANISMS); EUKARYOTA; PROKARYOTA;

EID: 68249086335     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2009.03.009     Document Type: Review

References (75)

1. Chiti F., and Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75 (2006) 333-366
2. Ventura S., and Villaverde A. Protein quality in bacterial inclusion bodies. Trends Biotechnol. 24 (2006) 179-185
3. Fernandez-Busquets X., et al. Recent structural and computational insights into conformational diseases. Curr. Med. Chem. 15 (2008) 1336-1349
4. Bowden G.A., et al. Structure and morphology of protein inclusion bodies in Escherichia coli. Biotechnology (N. Y.) 9 (1991) 725-730
5. Carrio M., et al. Amyloid-like properties of bacterial inclusion bodies. J. Mol. Biol. 347 (2005) 1025-1037
6. Schrodel A., and de Marco A. Characterization of the aggregates formed during recombinant protein expression in bacteria. BMC Biochem. 6 (2005) 10
7. Morell M., et al. Inclusion bodies: specificity in their aggregation process and amyloid-like structure. Biochim. Biophys. Acta 1783 (2008) 1815-1825
8. Wang L., et al. Bacterial inclusion bodies contain amyloid-like structure. PLoS Biol. 6 (2008) e195
9. Jahn T.R., and Radford S.E. Folding versus aggregation: polypeptide conformations on competing pathways. Arch. Biochem. Biophys. 469 (2008) 100-117
10. Jahn T.R., and Radford S.E. The yin and yang of protein folding. FEBS J. 272 (2005) 5962-5970
11. Carrio M.M., and Villaverde A. Localization of chaperones DnaK and GroEL in bacterial inclusion bodies. J. Bacteriol. 187 (2005) 3599-3601
12. Doglia S.M., et al. Fourier transform infrared spectroscopy analysis of the conformational quality of recombinant proteins within inclusion bodies. Biotechnol. J. 3 (2008) 193-201
13. de Groot N.S., and Ventura S. Protein activity in bacterial inclusion bodies correlates with predicted aggregation rates. J. Biotechnol. 125 (2006) 110-113
14. Garcia-Fruitos E., et al. Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins. Microb. Cell Fact. 4 (2005) 27
15. Ami D., et al. Kinetics of inclusion body formation studied in intact cells by FT-IR spectroscopy. FEBS Lett. 579 (2005) 3433-3436
16. Morgan G.J., et al. Exclusion of the native alpha-helix from the amyloid fibrils of a mixed alpha/beta protein. J. Mol. Biol. 375 (2008) 487-498
17. +], a heritable prion-like factor of S. cerevisiae. Cell 89 (1997) 811-819
18. Taylor G., et al. Size and density of protein inclusion bodies. Biotechnology 4 (1986) 553-557
19. Balguerie A., et al. Domain organization and structure-function relationship of the HET-s prion protein of Podospora anserina. EMBO J. 22 (2003) 2071-2081
20. Jarrett J.T., and Lansbury Jr. P.T. Seeding 'one-dimensional crystallization' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?. Cell 73 (1993) 1055-1058
21. Krebs M.R., et al. Observation of sequence specificity in the seeding of protein amyloid fibrils. Protein Sci. 13 (2004) 1933-1938
22. Jones E.M., and Surewicz W.K. Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids. Cell 121 (2005) 63-72
23. de Groot N.S., et al. Studies on bacterial inclusion bodies. Future Microbiol. 3 (2008) 423-435
24. Carrio M.M., et al. Dynamics of in vivo protein aggregation: building inclusion bodies in recombinant bacteria. FEMS Microbiol. Lett. 169 (1998) 9-15
25. Ventura S., et al. Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 7258-7263
26. Fernandez-Escamilla A.M., et al. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat. Biotechnol. 22 (2004) 1302-1306
27. Tartaglia G.G., and Vendruscolo M. The Zyggregator method for predicting protein aggregation propensities. Chem. Soc. Rev. 37 (2008) 1395-1401
28. Conchillo-Sole O., et al. AGGRESCAN: a server for the prediction and evaluation of 'hot spots' of aggregation in polypeptides. BMC Bioinformatics 8 (2007) 65
29. Morimoto A., et al. Analysis of the secondary structure of beta-amyloid (Aβ42) fibrils by systematic proline replacement. J. Biol. Chem. 279 (2004) 52781-52788
30. West M.W., et al. De novo amyloid proteins from designed combinatorial libraries. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 11211-11216
31. Idicula-Thomas S., and Balaji P.V. Understanding the relationship between the primary structure of proteins and its propensity to be soluble on overexpression in Escherichia coli. Protein Sci. 14 (2005) 582-592
32. Tartaglia G.G., et al. Life on the edge: a link between gene expression levels and aggregation rates of human proteins. Trends Biochem. Sci. 32 (2007) 204-206
33. Hoffmann F., and Rinas U. Roles of heat-shock chaperones in the production of recombinant proteins in Escherichia coli. Adv. Biochem. Eng. Biotechnol. 89 (2004) 143-161
34. Espargaro A., et al. Kinetic and thermodynamic stability of bacterial intracellular aggregates. FEBS Lett. 582 (2008) 3669-3673
35. Uversky V.N. Amyloidogenesis of natively unfolded proteins. Curr. Alzheimer Res. 5 (2008) 260-287
36. Klein J., and Dhurjati P. Protein aggregation kinetics in an Escherichia coli strain overexpressing a Salmonella typhimurium CheY mutant gene. Appl. Environ. Microbiol. 61 (1995) 1220-1225
37. Espargaro A., et al. The in vivo and in vitro aggregation properties of globular proteins correlate with their conformational stability: the SH3 case. J. Mol. Biol. 378 (2008) 1116-1131
38. Chiti F., and Dobson C.M. Amyloid formation by globular proteins under native conditions. Nat. Chem. Biol. 5 (2009) 15-22
39. Calloni G., et al. Investigating the effects of mutations on protein aggregation in the cell. J. Biol. Chem. 280 (2005) 10607-10613
40. Mayer S., et al. Correlation of levels of folded recombinant p53 in Escherichia coli with thermodynamic stability in vitro. J. Mol. Biol. 372 (2007) 268-276
41. Canet D., et al. Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme. Nat. Struct. Biol. 9 (2002) 308-315
42. Wigley W.C., et al. Protein solubility and folding monitored in vivo by structural complementation of a genetic marker protein. Nat. Biotechnol. 19 (2001) 131-136
43. Hammarstrom P., et al. D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis?. Biochemistry 42 (2003) 6656-6663
44. Wang W., and Hecht M.H. Rationally designed mutations convert de novo amyloid-like fibrils into monomeric beta-sheet proteins. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 2760-2765
45. Walsh D.M., et al. Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. Biochem. Soc. Trans. 30 (2002) 552-557
46. Bucciantini M., et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416 (2002) 507-511
47. Merlini G., and Bellotti V. Molecular mechanisms of amyloidosis. N. Engl. J. Med. 349 (2003) 583-596
48. Ami D., et al. Effects of recombinant protein misfolding and aggregation on bacterial membranes. Biochim. Biophys. Acta 1794 (2009) 263-269
49. Gonzalez-Montalban N., et al. Amyloid-linked cellular toxicity triggered by bacterial inclusion bodies. Biochem. Biophys. Res. Commun. 355 (2007) 637-642
50. Lindner A.B., et al. Asymmetric segregation of protein aggregates is associated with cellular aging and rejuvenation. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 3076-3081
51. +] on amyloid toxicity manifested in Escherichia coli strain BL21. Prion 2 (2008) 37-41
52. Kim W., et al. A high-throughput screen for compounds that inhibit aggregation of the Alzheimer's peptide. ACS Chem. Biol. 1 (2006) 461-469
53. Hart R.A., et al. Protein composition of Vitreoscilla hemoglobin inclusion bodies produced in Escherichia coli. J. Biol. Chem. 265 (1990) 12728-12733
54. Monsellier E., et al. The distribution of residues in a polypeptide sequence is a determinant of aggregation optimized by evolution. Biophys. J. 93 (2007) 4382-4391
55. Shorter J., and Lindquist S. Hsp104, Hsp70 and Hsp40 interplay regulates formation, growth and elimination of Sup35 prions. EMBO J. 27 (2008) 2712-2724
56. Makin O.S., and Serpell L.C. X-ray diffraction studies of amyloid structure. Methods Mol. Biol. 299 (2005) 67-80
57. Tycko R. Solid-state NMR as a probe of amyloid structure. Protein Pept. Lett. 13 (2006) 229-234
58. Barnham K.J., et al. Delineating common molecular mechanisms in Alzheimer's and prion diseases. Trends Biochem. Sci. 31 (2006) 465-472
59. Nagy Z. Cell cycle regulatory failure in neurones: causes and consequences. Neurobiol. Aging 21 (2000) 761-769
60. Singh D., et al. Mixed oligomer formation between human αA-crystallin and its cataract-causing G98R mutant: structural, stability and functional differences. J. Mol. Biol. 373 (2007) 1293-1304
61. Lopes D.H., et al. Amyloidogenicity and cytotoxicity of recombinant mature human islet amyloid polypeptide (rhIAPP). J. Biol. Chem. 279 (2004) 42803-42810
62. Wang J., et al. Overexpression and purification of recombinant atrial natriuretic peptide using hybrid fusion protein REF-ANP in Escherichia coli. Protein Expr. Purif. 28 (2003) 49-56
63. Ding M.S., et al. Sheng Wu Gong Cheng Xue Bao 21 (2005) 198-203
64. Umetsu M., et al. Nondenaturing solubilization of β2 microglobulin from inclusion bodies by L-arginine. Biochem. Biophys. Res. Commun. 328 (2005) 189-197
65. Ishikawa H., et al. Large-scale preparation of recombinant human calcitonin from a multimeric fusion protein produced in Escherichia coli. J. Biosci. Bioeng. 87 (1999) 296-301
66. Gerhartz B., et al. Two stable unfolding intermediates of the disease-causing L68Q variant of human cystatin C. Biochemistry 37 (1998) 17309-17317
67. Swietnicki W., et al. Familial mutations and the thermodynamic stability of the recombinant human prion protein. J. Biol. Chem. 273 (1998) 31048-31052
68. Nagao Y., et al. DMSO and glycerol reduce bacterial death induced by expression of truncated N-terminal huntingtin with expanded polyglutamine tracts. Biochim. Biophys. Acta 1502 (2000) 247-256
69. Helms L.R., and Wetzel R. Specificity of abnormal assembly in immunoglobulin light chain deposition disease and amyloidosis. J. Mol. Biol. 257 (1996) 77-86
70. Redwan E.-R.M., et al. Synthesis of the human insulin gene: protein expression, scaling up and bioactivity. Prep. Biochem. Biotechnol. 38 (2008) 24-39
71. Paladini R.D., et al. cDNA cloning and bacterial expression of the human type I keratin 16. Biochem. Biophys. Res. Commun. 215 (1995) 517-523
72. Leinweber B., et al. Aggregation of ALS mutant superoxide dismutase expressed in Escherichia coli. Free Radic. Biol. Med. 36 (2004) 911-918
73. Li M., and aand Su Z. Refolding human lysozyme produced as an inclusion body by urea concentration and pH gradient ion exchange chromatography. Chromatographia 56 (2002) 33-38
74. Rajan R.S., et al. Specificity in intracellular protein aggregation and inclusion body formation. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 13060-13065
75. Milewski M.I., et al. Aggregation of misfolded proteins can be a selective process dependent upon peptide composition. J. Biol. Chem. 277 (2002) 34462-34470